Nephros (NEPH) EPS (Basic) Growth (1y) (2011 - 2026)
Nephros (NEPH) EPS (Basic) Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 25.48% |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | -31.18% |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | - |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 1.81% |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | - |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 18.95% |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 4.17% |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | -191.06% |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 37.39% |
| 10 | Nephros | 45.71 Mn | 41.01 Mn | 4.03 Mn | 393.15% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 393.15% |
| Mar 31, 2026 | 103.21% |
| Dec 31, 2025 | -83.11% |
| Sep 30, 2025 | 82.98% |
| Jun 30, 2025 | 181.31% |
| Mar 31, 2025 | -328.19% |
| Dec 31, 2024 | 154.92% |
| Sep 30, 2024 | 199.76% |
| Jun 30, 2024 | 34.61% |
| Mar 31, 2024 | 33.35% |
| Dec 31, 2023 | 29.37% |
| Sep 30, 2023 | 94.45% |
| Jun 30, 2023 | 64.00% |
| Mar 31, 2023 | 85.05% |
| Dec 31, 2022 | 19.03% |
| Sep 30, 2022 | -157.75% |
| Jun 30, 2022 | 2.07% |
| Mar 31, 2022 | -229.57% |
| Dec 31, 2021 | -21.90% |
| Sep 30, 2021 | -2.59% |